Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma

Oncology Reports

Volumn 15, Issue 2, 2006, Pages 323-328

  Takahashi, Yoshiaki ^a   Noguchi, Tsuyoshi ^b   Takeno, Shinsuke ^b   Kimura, Yasuhiko ^b   Okubo, Masahiko ^a   Kawahara, Katsunobu ^b  

^a Okubo Hospital   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

Esophageal squamous cell carcinoma; p53; p63

Indexed keywords

CKAP4 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN P53; TUMOR MARKER;

AGED; ARTICLE; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33744486389     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.2.323     Document Type: Article

References (28)

1. Piason P, Parkin DM, Bray F and Ferlay J: Estimates of the world-wide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29, 1999. (Pubitemid 29409471)
2. Yang A, Kaghad M, Wang Y, et al: p63, a p53 homolog at 3q27-29 encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316, 1998. (Pubitemid 128379271)
3. Liefer KM, Koster MI, Wang XJ, Yang A, McKoen F and Roop DR: Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res 60: 4016-4020, 2000. (Pubitemid 30636575)
4. Osada M, Ohba M, Kawahara C, et al: Cloning and functional analysis of human p51, which structurally resembles p53. Nat Med 4: 839-843, 1998. (Pubitemid 28331028)
5. Yang A and McKoen F: p63 and p73: p53 mimics, menaces and more. Nat Rev Mol Cell Biol 1: 199-207, 2000.
6. Crook T, Nicholls JM, Brooks L, O'Nions J and Allday MJ: High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 19: 3439-3444, 2000. (Pubitemid 30479339)
7. Nylander K, Coates PJ and Hall PA: Characterization of the expression pattern of p63α and ΔNp63α in benign and malignant oral epithelial lesion. Int J Cancer 87: 368-372, 2000. (Pubitemid 30451647)
8. Nishi H, Isaka K, Sagawa Y, et al: Mutation and transcription analyses of the p63 gene in cervical carcinoma. Int J Oncol 15: 1149-1153, 1999.
9. Park BJ, Lee SJ, Kim JI, et al: Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 60: 3370-3374, 2000. (Pubitemid 30482148)
10. Yamaguchi K, Patturajan M, Trink B, et al: Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients. Int J Cancer 89: 524-528, 2000.
11. Sunabara M, Shishikura T, Takahashi M, et al: Mutational analysis of p51A/TAp63 gamma, a p53 homolog, in non-small cell lung cancer and breast cancer. Oncogene 18: 3761-3765, 1999. (Pubitemid 29338509)
12. Senoo M, Tsuchiya I, Matsumura Y, et al: Transcriptional dysregulation of the p73L/p63/p51/p40/KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51. Br J Cancer 84: 1235-1241, 2001. (Pubitemid 32511342)
13. Glickman JN, Yang A, Shahsafaei A, McKoen F and Odze RD: Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol 32: 1157-1165, 2001. (Pubitemid 33104425)
14. Hu H, Xia SH, Li AD, et al: Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 102: 580-583, 2002. (Pubitemid 35334464)
15. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S and Müller W: Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94: 2874-2881, 2002. (Pubitemid 34547686)
16. Ribeiro U Jr, Finkelstein SD, Safatle-Ribeiro AV, et al: p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer 83: 7-18, 1998. (Pubitemid 28299623)
17. Geddert H, Kiel S, Heep HJ, Gabbert HE and Sarbia M: The role of p63 and ΔNp63(p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol 34: 850-856, 2003. (Pubitemid 37169613)
18. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR and Bradley A: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713, 1999. (Pubitemid 29197649)
19. Yang A, Schweitzer R, Sun D, et al: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718, 1999. (Pubitemid 29197650)
20. Park JJ, Sun D, Quade BJ, et al: Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol 24: 1414-1419, 2000.
21. Urist MJ, Di Como CJ, Lu ML, et al: Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol 161: 1199-1206, 2002.
22. Starno S, Fontemaggi G, Costanzo A, et al: Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. J Biol Chem 277: 18817-18826, 2002. (Pubitemid 34952441)
23. Parsa R, Yang A, McKeon F and Green H: Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 113: 1099-1105, 1999. (Pubitemid 30013359)
24. Hall PA, Campbell SJ, O'Neill M, et al: The expression of the p53 homologue. p63α and ΔNp63α in normal and neoplastic cells. Carcinogenesis 21: 153-160, 2000. (Pubitemid 30098696)
25. Hibi K, Trink B, Patturajan M, et al: AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97: 5462-5467, 1999.
26. Faridoni-Laurens L, Bosq J, Janot F, et al: p73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? Oncogene 20: 5302-5312, 2001. (Pubitemid 32844062)
27. Pruneri G, Pignataro L, Manzotti M, et al: p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity. Lab Invest 82: 1327-1334, 2002. (Pubitemid 35191536)
28. Shimada A, Kato S, Enjo K, et al: The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. Cancer Res 59: 2781-2786, 1999. (Pubitemid 29283107)